急性乙托酚中毒后胆碱酯酶老化1例报告

Q4 Pharmacology, Toxicology and Pharmaceutics
B. Chefirat, El Haouaria Touer, Nour El Houda Bensaid, H. Rezk-kallah
{"title":"急性乙托酚中毒后胆碱酯酶老化1例报告","authors":"B. Chefirat, El Haouaria Touer, Nour El Houda Bensaid, H. Rezk-kallah","doi":"10.2174/1573408019666221221091244","DOIUrl":null,"url":null,"abstract":"\n\nAcute poisoning by Ethoprphos, an organophosphorus pesticide, leads to a veritable cholinergic syndrome whose diagnosis is based on the determination of cholinesterase activity. The treatment relies on the administration of atropine and pralidoxime to regenerate cholinesterases before their ageing.\n\n\n\nWe report a case of a two-year-old child, hospitalized for ethoprophos poisoning, with seizures associated with tight myosis, bronchial congestion, fever, and sialorrhea. The determination of butyrylcholinesterase and acetylcholinesterase showed low rates throughout the hospitalization. Knowing that pralidoxime was introduced from the 5th day of the poisoning, these rates could be explained by aging of cholinesterases. This phenomenon is well established for organophosphate pesticides (OPs) with methylated or ethyl alkyl groups in contrast to others that are much less documented such as dipropyled OPs such as ethoprophos. The recovery of the enzyme rates was very slow with good clinical improvement.\n\n\n\nEthoprophos poisoning may cause a life-threatening prognosis with a possible phenomenon of cholinesterase aging in the absence of rapid management with administration of pralidoxime.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cholinesterase Aging Phenomenon Following Acute Ethoprophos Poisoning: A Case Report\",\"authors\":\"B. Chefirat, El Haouaria Touer, Nour El Houda Bensaid, H. Rezk-kallah\",\"doi\":\"10.2174/1573408019666221221091244\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nAcute poisoning by Ethoprphos, an organophosphorus pesticide, leads to a veritable cholinergic syndrome whose diagnosis is based on the determination of cholinesterase activity. The treatment relies on the administration of atropine and pralidoxime to regenerate cholinesterases before their ageing.\\n\\n\\n\\nWe report a case of a two-year-old child, hospitalized for ethoprophos poisoning, with seizures associated with tight myosis, bronchial congestion, fever, and sialorrhea. The determination of butyrylcholinesterase and acetylcholinesterase showed low rates throughout the hospitalization. Knowing that pralidoxime was introduced from the 5th day of the poisoning, these rates could be explained by aging of cholinesterases. This phenomenon is well established for organophosphate pesticides (OPs) with methylated or ethyl alkyl groups in contrast to others that are much less documented such as dipropyled OPs such as ethoprophos. The recovery of the enzyme rates was very slow with good clinical improvement.\\n\\n\\n\\nEthoprophos poisoning may cause a life-threatening prognosis with a possible phenomenon of cholinesterase aging in the absence of rapid management with administration of pralidoxime.\\n\",\"PeriodicalId\":35405,\"journal\":{\"name\":\"Current Enzyme Inhibition\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Enzyme Inhibition\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573408019666221221091244\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408019666221221091244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

有机磷农药乙硫磷的急性中毒导致名副其实的胆碱能综合征,其诊断是基于测定胆碱酯酶活性。治疗依赖于阿托品和普拉多肟的管理,使胆碱酯酶在老化之前再生。我们报告一个两岁的孩子,住院的乙氧丙磷中毒,癫痫发作与紧肌收缩,支气管充血,发烧,和唾液。丁基胆碱酯酶和乙酰胆碱酯酶的测定在整个住院期间均呈低率。由于从中毒第5天开始引入了哌拉西肟,因此这些比率可以用胆碱酯酶的老化来解释。这一现象在具有甲基化或乙基烷基的有机磷农药(OPs)中得到了充分证实,与其他文献记载较少的有机磷农药(如二丙基有机磷农药,如乙丙磷)形成对比。酶率恢复缓慢,临床改善良好。如果不及时给予保拉多肟治疗,乙氧丙磷中毒可能导致危及生命的预后,并可能出现胆碱酯酶老化现象。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cholinesterase Aging Phenomenon Following Acute Ethoprophos Poisoning: A Case Report
Acute poisoning by Ethoprphos, an organophosphorus pesticide, leads to a veritable cholinergic syndrome whose diagnosis is based on the determination of cholinesterase activity. The treatment relies on the administration of atropine and pralidoxime to regenerate cholinesterases before their ageing. We report a case of a two-year-old child, hospitalized for ethoprophos poisoning, with seizures associated with tight myosis, bronchial congestion, fever, and sialorrhea. The determination of butyrylcholinesterase and acetylcholinesterase showed low rates throughout the hospitalization. Knowing that pralidoxime was introduced from the 5th day of the poisoning, these rates could be explained by aging of cholinesterases. This phenomenon is well established for organophosphate pesticides (OPs) with methylated or ethyl alkyl groups in contrast to others that are much less documented such as dipropyled OPs such as ethoprophos. The recovery of the enzyme rates was very slow with good clinical improvement. Ethoprophos poisoning may cause a life-threatening prognosis with a possible phenomenon of cholinesterase aging in the absence of rapid management with administration of pralidoxime.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Enzyme Inhibition
Current Enzyme Inhibition Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
1.30
自引率
0.00%
发文量
30
期刊介绍: Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信